Dr John Le Quesne

 

 

Senior Lecturer (University of Leicester)Dr J Le Quesne
Programme leader (MRC Toxicology Institute)
Diagnostic thoracic histopathologist

Contact details

Tel: +44 (0)116 2525541
Email: jlq2@le.ac.uk
Office: Hodgkin Building, Lancaster Road, Leicester LE1 9HN

Personal details

MA, PhD, MB, BS,

I am Senior Lecturer at the University of Leicester and also Programme Leader and Diagnostic Thoracic Histopathologist. I have Specialist training in histopathology at University Hospitals Leicester, Addenbrooke’s hospital Cambridge, Royal Brompton Hospital Chelsea, Papworth. I am Hospital Fellow of the Royal College of Pathologists.

Websites

http://www.ncbi.nlm.nih.gov/pubmed/?term=%28le+quesne+j%29+OR+%28lequesne+j%29

Education

MA Natural Sciences, Cambridge University
PhD (molecular biology), Universtiy of Leicester
MB BS, St Bartholomew’s and the Royal London School of Medicine
Specialist training in histopathology: University Hospitals Leicester, Addenbrooke’s hospital Cambridge, Royal Brompton Hospital Chelsea, Papworth Hospital
Fellow of the Royal College of Pathologists

NHS work

Diagnostic lung histopathology and cytopathology

Research

Tissue-based research
Lung cancer and mesothelioma biology
Improved diagnostic testing from FFPE tissue
Mechanistic toxicology of cancer therapy
Use of archival tissues for biomarker discovery
Molecular biology of early lung malignancy
Cell biological interpretation of tumour morphology and cytology
Large-scale tissue microarray construction and exploitation
Translational dysregulation as a predictive biomarker
Digital pathology and in silico image analysis/morphometry

Cell biology and biochemistry
mRNA helicases and translational control
Ameliorating toxicity of cancer therapies
Translational dysregulation and the malignant phenotype
Intratumoural competition
Pharmaceutical targeting of mRNAs as cancer therapy

Share this page:

NEWS

Powerful pre-clinical platform for anti-cancer drug and biomarker discovery

Pre-clinical models that can accurately predict outcomes in the clinic are much sort after in the field of cancer drug discovery and development.  Read about how patient derived explants offer many advantages and are the powerful model of choice. A copy of the review, published in the British Journal of Cancer, is available by clicking this link: PDE Platform

---------------------------------

SEND Study Success

Congratulations to Chris Avery, who with collaborating colleagues published findings of the SEND study, a multi-centre randomised trial using two different surgical protocols for mouth cancer treatment.  A nationwide first for this type of trial, using real-world data.  The paper, published in the British Journal of Cancer, is available by clicking this link: SEND Paper

---------------------------------

Centre Health and Wellbeing Group
Join up for a walk on the park Friday lunchtime - details here.

More information from Jenny McNair jm65@le.ac.uk

Contact Details

Leicester Cancer Research Centre
Robert Kilpatrick Clinical Sciences Building
University of Leicester
Leicester Royal Infirmary
Leicester LE2 7LX

T: +44 (0) 116 252 3170
E: cancerstudies@le.ac.uk

(Please note this email address should not be used for clinical referrals or patient correspondence)

Maps and Directions

Sat Nav users: 
LE1 5WW

Accessibility

AccessAble logo

The University of Leicester is committed to equal access to our facilities. DisabledGo has a detailed accessibility guide for the Robert Kilpatrick Clinical Sciences Building.

Seminars

.